Given the role of p22phox in LMP1-mediated NOX activation and the metabolic disorder characterizing NPC cells, we investigated whether p22phox overexpression is associated with LMP1 expression in NPC patients. This evidence concerns the gene CYBA and nasopharyngeal carcinoma.